CrossRef enabled

PAC Archives

Archive →

Pure Appl. Chem., 2007, Vol. 79, No. 12, pp. 2119-2127

http://dx.doi.org/10.1351/pac200779122119

Biomolecular approach to the design of potential drugs

Upendra K. Pandit

Van't Hoff Institute of Molecular Sciences, University of Amsterdam, Nieuwe Achtergracht 129, 1018 WS Amsterdam, The Netherlands

References

  • 1. J. D. Watson, F. H. C. Crick. Nature 171, 737 (1953). (http://dx.doi.org/10.1038/171737a0)
  • 2. (a). A. J. H. Nollet, C. M. Huting, U. K. Pandit. Tetrahedron 25, 5971 (1969); (http://dx.doi.org/10.1016/S0040-4020(01)83104-5)
  • 2. (b). A. J. H. Nollet, U. K. Pandit. Tetrahedron 25, 5983 (1969); (http://dx.doi.org/10.1016/S0040-4020(01)83105-7)
  • 2. (c). A. J. H. Nollet, U. K. Pandit. Tetrahedron 25, 5989 (1969); (http://dx.doi.org/10.1016/S0040-4020(01)83106-9)
  • 2. (d). H. De Koning, U. K. Pandit. Recl. Trav. Chim. Pays-Bas 91, 874 (1971);
  • 2. (e). H. De Koning, U. K. Pandit. Recl. Trav. Chim. Pays-Bas 91, 1069 (1971);
  • 2. (f). F. M. Kasperson, U. K. Pandit. J. Chem. Soc. Trans. 1 1617 (1975);
  • 2. (g). F. M. Kasperson, U. K. Pandit. J. Chem. Soc. Trans. 1 1798 (1975).
  • 3. (a). V. V. Demidov. Drug Discov. Today 153 (2002); (http://dx.doi.org/10.1016/S1359-6446(01)02105-5)
  • 3. (b). V. V. Demidov. Expert Rev. Mol. Diag. 2, 89 (2002).
  • 4. K. N. Ganesh, P. E. Nielsen. Curr. Org. Chem. 4, 916 (2000). (http://dx.doi.org/10.2174/1385272003375969)
  • 5. (a). U. K. Pandit, W. F. A. Grose, T. A. Eggelte. Synth. Commun. 2, 345 (1972); (http://dx.doi.org/10.1080/00397917208081778)
  • 5. (b). G. J. Koomen. Recl. Trav. Chim. Pays-Bas 112, 111 (1988);
  • 5. (c). K. Izawa, H. Shiragami. Pure Appl. Chem. 70, 313 (1998). (http://dx.doi.org/10.1351/pac199870020313)
  • 6. S. L. Sacks, B. Wilson. Adv. Exp. Med. Biol. 458, 135 (1999).
  • 7. L. Stryer. Biochemistry, 3rd ed., p. 615, Freeman, New York (1988).
  • 8. (a). M. A. Moore, F. Ahmed, R. B. Dunlap. Biochemistry 25, 3311 (1986); (http://dx.doi.org/10.1021/bi00359a034)
  • 8. (b). L. W. Hardy, J. S. Finer Moore, W. R. Montfort, M. O. Jones, D. V. Santi, R. M. Stroud. Science 235, 448 (1987); (http://dx.doi.org/10.1126/science.3099389)
  • 8. (c). K. M. Perry, C. W. Carreras, L. C. Chang, D. V. Santi, R. M. Stroud. Biochemistry 32, 7116 (1993). (http://dx.doi.org/10.1021/bi00079a007)
  • 9. P. F. C. van der Meij, T. B. R. A. Chen, E. Hilhorst, E. R. De Waard, U. K. Pandit. Tetrahedron 43, 4015 (1987). (http://dx.doi.org/10.1016/S0040-4020(01)81684-7)
  • 10. U. K. Pandit. Recl. Trav. Chim. Pays-Bas 107, 111 (1988).
  • 11. J. W. G. Meissner. Model Studies of the Thymidylate Synthase Reaction, Design of Mechanism-Based Potential Inhibitors of DNA Biosynthesis, Ph.D. thesis, University of Amsterdam (1993).
  • 12. A. Wolfenden. Acc. Chem. Res. 5, 10 (1972). (http://dx.doi.org/10.1021/ar50049a002)
  • 13. G. M. Blackburn, J. H. Pickard, S. Cesaro-Tadia, D. Lagos, A. Mekhalfia, L. Partridge, A. Pluckthun. Pure Appl. Chem. 76, 983 (2004). (http://dx.doi.org/10.1351/pac200476050983)
  • 14. G. Legler. In Iminosugars as Glucosidase Inhibitors, A. E. Stutz (Ed.), pp. 31-67, Wiley-VCH, Weinheim (1999).
  • 15. E. Beutler, G. A. Grabowski. In The Metabolic and Molecular Basis of Inherited Disease, C. R. Scriver, A. L. Beaudet, W. S. Sly, D. Valle (Eds.), pp. 2641-2670, McGraw-Hill, New York (1995).
  • 16. S. van Weely, M. Brandsma, A. Strijland, J. M. Tager, J. M. F. G. Aerts. Biochim. Biophys. Acta 1181, 55 (1993).
  • 17. H. S. Overkleeft, H. H. Renkema, J. Neele, P. Vianello, I. O. Hung, A. Strijland, A. M. van der Burg, G. J. Koomen, U. K. Pandit, J. M. F. G. Aerts. J. Biol. Chem. 273, 26522 (1998). (http://dx.doi.org/10.1074/jbc.273.41.26522)